Nicholas A. Saccomano, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nicholas A. Saccomano, Ph.D.
Nicholas A. Saccomano, Ph.D. is recorded as CEO at OnKure Therapeutics, Inc. (OKUR). OnKure Therapeutics, Inc. reported in an 8-K filed May 13, 2024 that Nicholas A. Saccomano, Ph.D. was appointed President and Chief Executive Officer.
“Following the closing of the Proposed Transactions, Dr. Saccomano and Mr. Leverone will be named the President and Chief Executive Officer and Chief Financial Officer, respectively, of Reneo.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-10-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at OnKure Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Nicholas A. Saccomano CEO, Board Member
- Nicholas Saccomano CEO, Board Member
- Andrew Phillips Chairman, Board Member
- Jason Leverone CFO
- Jennifer P. Lam CFO
- Michael P. Cruse COO
- Andrew Philips, Ph.D. Board Member
- Continuing Directors Board Member
- Dr. Liam Ratcliffe Board Member
- Edward T. Mathers Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.